4527.T
4527.T
JP3982400008
ROHTO PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 343.725.000.000 308.625.000.000
11.4%
Cost of Revenue 151.030.000.000 134.232.000.000
12.5%
Gross Profit 192.695.000.000 174.393.000.000
10.5%
151.573.000.000 136.154.000.000
11.3%
Operating Income 41.122.000.000 38.239.000.000
7.5%
Pretax Income 46.821.000.000 41.626.000.000
12.5%
Net Income Common Stockholders 34.247.000.000 30.841.000.000
11.0%
-- --
--
-- --
--
ende